BridgeMD
New treatment option for Narcolepsy Type 1
Official title A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
ClinicalTrials.gov ID: NCT07096674
What this study is testing
What is ORX750?
ORX750 is an investigational medicine, given as a pill taken by mouth, being studied as a potential treatment for narcolepsy type 1.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- This study is a long-term extension (LTE) of the parent Study ORX750 0201, and will provide long-term open-label safety, tolerability, and efficacy of ORX750 in participants with narcolepsy type 1 (NT1), narcolepsy type 2 (NT2), and idiopathic hypersomnia (IH).
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Diagnosis of narcolepsy (NT1 or NT2) or IH who was eligible for and completed the full treatment period in the eligible parent study ORX750-0201...
- Is willing and able to adhere to additional protocol requirements
You likely can't join if
- Development of any new disease/disorder that in the opinion of the investigator would make the participant unable to continue the study
- Unable to refrain from excluded medications, including those used for treatment of narcolepsy or idiopathic hypersomnia
The study team makes the final eligibility decision.
Where it's taking place
- Auburn, Alabama, United States
- Santa Ana, California, United States
- Miami, Florida, United States
- Orlando, Florida, United States
- Winter Park, Florida, United States
- Atlanta, Georgia, United States
- Sterling Heights, Michigan, United States
- Henderson, Nevada, United States
- Denver, North Carolina, United States
- Huntersville, North Carolina, United States
- Cincinnati, Ohio, United States
- Dublin, Ohio, United States
- Abington, Pennsylvania, United States
- Willow Grove, Pennsylvania, United States
- North Charleston, South Carolina, United States
- Austin, Texas, United States
- El Paso, Texas, United States
- Toronto, Ontario, Canada
- Bologna, BO, Italy
- Verona, VR, Italy
+ 2 more site(s).
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Auburn, Alabama, United States; Santa Ana, California, United States; Miami, Florida, United States; Orlando, Florida, United States; Winter Park, Florida, United States; Atlanta, Georgia, United States and 16 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.